Zhang Bao-Jie, Chen Deng, Dekker Frank J, Quax Wim J
University of Groningen, Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen 9713 AV, The Netherlands.
Cancer Drug Resist. 2020 Oct 9;3(4):791-803. doi: 10.20517/cdr.2020.58. eCollection 2020.
Epigenetic regulation refers to alterations to the chromatin template that collectively establish differential patterns of gene transcription. Post-translational modifications of the histones play a key role in epigenetic regulation of gene transcription. In this review, we provide an overview of recent studies on the role of histone modifications in carcinogenesis. Since tumour-selective ligands such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) are well-considered as promising anti-tumour therapies, we summarise strategies for improving TRAIL sensitivity by inhibiting aberrant histone modifications in cancers. In this perspective we also discuss new epigenetic drug targets for enhancing TRAIL-mediated apoptosis.
表观遗传调控是指染色质模板发生改变,这些改变共同建立基因转录的差异模式。组蛋白的翻译后修饰在基因转录的表观遗传调控中起关键作用。在本综述中,我们概述了关于组蛋白修饰在致癌作用中作用的近期研究。由于肿瘤选择性配体,如肿瘤坏死因子相关凋亡诱导配体(TRAIL)被公认为是有前景的抗肿瘤疗法,我们总结了通过抑制癌症中异常组蛋白修饰来提高TRAIL敏感性的策略。从这个角度,我们还讨论了增强TRAIL介导的凋亡的新的表观遗传药物靶点。